Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2025-12-25 @ 12:14 AM
NCT ID:
NCT05628558
Eligibility Criteria:
Inclusion Criteria:
* Males with a mild or moderate hemophilia A,
* Therapeutic test with desmopressin realized in the last 10 years,
* Factor VIII levels measurements realized at least 2 times during the therapeutic test, just before the desmopressin infusion and 30 or 60 minutes after,
* Complete genotyping of the F8 gene for genetic diagnosis of hemophilia
Exclusion Criteria:
* Patients with an anti-factor VIII inhibitor
* Refusal to participate in the study
* Unable to understand the study's French letter of non-opposition and information
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
2 Years
Maximum Age:
80 Years
Study:
NCT05628558
Study Brief:
Protocol Section:
NCT05628558